SCHEDULE: EARNEST Partners Boosts Core Labs Stake to 6.9%

EARNEST Partners LLC has filed an amended Schedule 13G, reporting a 6.9% beneficial ownership stake in Core Laboratories Inc. /DE/ common stock.

Summary

• EARNEST Partners LLC reported beneficial ownership of 3,221,043 shares of Core Laboratories Inc. /DE/ common stock.
• This ownership represents 6.9% of the class of securities.
• EARNEST Partners LLC holds sole voting power over 2,026,540 shares and shared voting power over 298,965 shares.
• They possess sole dispositive power over 3,221,043 shares and no shared dispositive power.
• The filing is an Amendment No. 12 to Schedule 13G, indicating an update to a previously reported beneficial ownership.
• The event requiring this filing occurred on December 31, 2025.
• EARNEST Partners LLC is classified as an investment adviser.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, factual report of institutional ownership, providing transparency without indicating specific positive or negative company performance or outlook.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional ownership filings like this Schedule 13G provide transparency into significant investor positions, which can influence market perception and liquidity for companies like Core Laboratories, an oilfield services provider. This filing indicates continued institutional interest in the company.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional holder's stake, which can be viewed as a disclosure of existing ownership and potentially a vote of confidence from a large investor.

Key Dates

Keywords

Core Laboratories, EARNEST Partners, beneficial ownership, Schedule 13G, common stock, investment adviser, institutional ownership